174 related articles for article (PubMed ID: 34754245)
1. Circulating miRNAs as Potential Biomarkers in Prostate Cancer Patients Undergoing Radiotherapy.
Kachris S; Papadaki C; Rounis K; Tsitoura E; Kokkinaki C; Nikolaou C; Sourvinos G; Mavroudis D
Cancer Manag Res; 2021; 13():8257-8271. PubMed ID: 34754245
[TBL] [Abstract][Full Text] [Related]
2. Circulating miRNAs as Biomarkers for Prostate Cancer Diagnosis in Subjects with Benign Prostatic Hyperplasia.
Jin W; Fei X; Wang X; Chen F; Song Y
J Immunol Res; 2020; 2020():5873056. PubMed ID: 32455140
[TBL] [Abstract][Full Text] [Related]
3. The association of let-7c, miR-21, miR-145, miR-182, and miR-221 with clinicopathologic parameters of prostate cancer in patients diagnosed with low-risk disease.
Kurul NO; Ates F; Yilmaz I; Narli G; Yesildal C; Senkul T
Prostate; 2019 Jul; 79(10):1125-1132. PubMed ID: 31045265
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNAs as Biomarkers for Prostate Cancer Detection and Metastasis Development Prediction.
Bidarra D; Constâncio V; Barros-Silva D; Ramalho-Carvalho J; Moreira-Barbosa C; Antunes L; Maurício J; Oliveira J; Henrique R; Jerónimo C
Front Oncol; 2019; 9():900. PubMed ID: 31572685
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-106b serves as a prognostic biomarker and is associated with cell proliferation, migration, and invasion in osteosarcoma.
Xu K; Xiong W; Zhao S; Wang B
Oncol Lett; 2019 Sep; 18(3):3342-3348. PubMed ID: 31452813
[TBL] [Abstract][Full Text] [Related]
6. Circulating MicroRNAs Regulating DNA Damage Response and Responsiveness to Cisplatin in the Prognosis of Patients with Non-Small Cell Lung Cancer Treated with First-Line Platinum Chemotherapy.
Papadaki C; Monastirioti A; Rounis K; Makrakis D; Kalbakis K; Nikolaou C; Mavroudis D; Agelaki S
Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32438598
[TBL] [Abstract][Full Text] [Related]
7. Functional roles and potential clinical application of miRNA-345-5p in prostate cancer.
Tinay I; Tan M; Gui B; Werner L; Kibel AS; Jia L
Prostate; 2018 Sep; 78(12):927-937. PubMed ID: 29748958
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of microRNA expression profiling in non small cell lung cancer.
Markou A; Sourvinou I; Vorkas PA; Yousef GM; Lianidou E
Lung Cancer; 2013 Sep; 81(3):388-396. PubMed ID: 23756108
[TBL] [Abstract][Full Text] [Related]
9. Incorporating MicroRNA into Molecular Phenotypes of Circulating Tumor Cells Enhances the Prognostic Accuracy for Patients with Metastatic Breast Cancer.
Tan W; Liang G; Xie X; Jiang W; Tan L; Sanders AJ; Liu Z; Ling Y; Zhong W; Tian Z; Lin W; Gong C
Oncologist; 2019 Nov; 24(11):e1044-e1054. PubMed ID: 31300482
[TBL] [Abstract][Full Text] [Related]
10. Validation of expression patterns for nine miRNAs in 204 lymph-node negative breast cancers.
Jonsdottir K; Janssen SR; Da Rosa FC; Gudlaugsson E; Skaland I; Baak JP; Janssen EA
PLoS One; 2012; 7(11):e48692. PubMed ID: 23144930
[TBL] [Abstract][Full Text] [Related]
11. Improved biochemical outcome with adjuvant radiotherapy after radical prostatectomy for prostate cancer with poor pathologic features.
Vargas C; Kestin LL; Weed DW; Krauss D; Vicini FA; Martinez AA
Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):714-24. PubMed ID: 15708249
[TBL] [Abstract][Full Text] [Related]
12. MiR-145 detection in urinary extracellular vesicles increase diagnostic efficiency of prostate cancer based on hydrostatic filtration dialysis method.
Xu Y; Qin S; An T; Tang Y; Huang Y; Zheng L
Prostate; 2017 Jul; 77(10):1167-1175. PubMed ID: 28617988
[TBL] [Abstract][Full Text] [Related]
13. Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.
Sun X; Yang Z; Zhang Y; He J; Wang F; Su P; Han J; Song Z; Fei Y
Int J Clin Exp Pathol; 2015; 8(7):8394-401. PubMed ID: 26339409
[TBL] [Abstract][Full Text] [Related]
14. Elevated serum microRNA levels associate with absence of high-grade prostate cancer in a retrospective cohort.
Mihelich BL; Maranville JC; Nolley R; Peehl DM; Nonn L
PLoS One; 2015; 10(4):e0124245. PubMed ID: 25874774
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-106b-25 cluster expression is associated with early disease recurrence and targets caspase-7 and focal adhesion in human prostate cancer.
Hudson RS; Yi M; Esposito D; Glynn SA; Starks AM; Yang Y; Schetter AJ; Watkins SK; Hurwitz AA; Dorsey TH; Stephens RM; Croce CM; Ambs S
Oncogene; 2013 Aug; 32(35):4139-47. PubMed ID: 22986525
[TBL] [Abstract][Full Text] [Related]
16. Association of microRNA-126 expression with clinicopathological features and the risk of biochemical recurrence in prostate cancer patients undergoing radical prostatectomy.
Sun X; Liu Z; Yang Z; Xiao L; Wang F; He Y; Su P; Wang J; Jing B
Diagn Pathol; 2013 Dec; 8():208. PubMed ID: 24350576
[TBL] [Abstract][Full Text] [Related]
17. A Prognostic Role for Circulating microRNAs Involved in Macrophage Polarization in Advanced Non-Small Cell Lung Cancer.
Monastirioti A; Papadaki C; Rounis K; Kalapanida D; Mavroudis D; Agelaki S
Cells; 2021 Aug; 10(8):. PubMed ID: 34440757
[TBL] [Abstract][Full Text] [Related]
18. Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer.
Nguyen HC; Xie W; Yang M; Hsieh CL; Drouin S; Lee GS; Kantoff PW
Prostate; 2013 Mar; 73(4):346-54. PubMed ID: 22887127
[TBL] [Abstract][Full Text] [Related]
19. Detection of miRNAs in urine of prostate cancer patients.
Stuopelytė K; Daniūnaitė K; Jankevičius F; Jarmalaitė S
Medicina (Kaunas); 2016; 52(2):116-24. PubMed ID: 27170485
[TBL] [Abstract][Full Text] [Related]
20. Activin A regulates microRNAs and gene expression in LNCaP cells.
Ottley EC; Nicholson HD; Gold EJ
Prostate; 2016 Aug; 76(11):951-63. PubMed ID: 27018851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]